In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.

Bio Reactor

Advances in the genomic sciences and biotechnology have led to an unprecedented need to rapidly isolate novel biotherapeutics for preclinical and clinical testing and then bring them to the market.

Sepragen Corporation specializes in providing advanced liquid chromatography devices to separate and purify biomolecules from the development stage to commercial production of biological drugs.
The QuantaSep® Advantage
Sepragen provides scientists and engineers the best equipment to grow cells and purify molecules. Our products dramatically improve throughput, productivity and ease of use, and significantly reduce footprint, time and cost.